FIELD: biotechnology.
SUBSTANCE: compositions and methods for the treatment of ophthalmic disorders in a subject are described. A vector based on an adeno associated virus that includes a nucleic acid molecule containing a sequence that encodes CNGA3, a vector based on an adeno associated virus that includes a nucleic acid molecule containing a sequence that encodes CNGB3, and a vector based on an adeno associated virus that includes a nucleic acid molecule containing a sequence that encodes REP-1 are also described.
EFFECT: invention expands the arsenal of means for the treatment of ophthalmic diseases.
39 cl, 12 dwg, 23 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISORDERS AND DISEASES RELATED TO RDH12 | 2017 |
|
RU2764920C2 |
| GENE THERAPY FOR THE TREATMENT OF HEMOPHILIA A | 2017 |
|
RU2762257C2 |
| METHODS FOR ENHANCING BIOLOGICAL ACTIVITY OF RECOMBINANT ADENO ASSOCIATED VIRUS PRODUCED BY BACULOVIRUS SYSTEM | 2017 |
|
RU2762948C2 |
| INTRATHECAL ADMINISTRATION OF VECTORS BASED ON ADENO ASSOCIATED VIRUSES FOR GENE THERAPY | 2016 |
|
RU2775138C2 |
| COMPOSITION AND METHOD FOR TREATING A COMPLEMENT-MEDIATED DISEASE | 2016 |
|
RU2727411C2 |
| THERAPEUTIC COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | 2015 |
|
RU2711147C2 |
| COMPOSITIONS AND METHODS OF TREATING MPS1 | 2014 |
|
RU2708318C2 |
| OPTIMIZED CLN1 GENES AND EXPRESSION CASSETTES, AND THEIR APPLICATION | 2017 |
|
RU2764919C2 |
| PROMOTER COMPOSITIONS | 2014 |
|
RU2742435C2 |
| ADENO-ASSOCIATED VIRUS VECTOR | 2015 |
|
RU2743382C2 |
